Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity

Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies

(2009) Elizabeth W. Karlson et al.   ARTHRITIS AND RHEUMATISM

Proteomic toolbox for autoimmunity research

(2009) Tianfu Wu et al.   AUTOIMMUNITY REVIEWS

Psoriasis, syndrome métabolique et ses composants

(2008) J.-P. Ortonne   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

(2008) Robert Biesen et al.   ARTHRITIS AND RHEUMATISM

At the horizon of innovative therapy in rheumatology: new biologic agents

(2008) Axel Finckh et al.   CURRENT OPINION IN RHEUMATOLOGY

Cytokines as Therapeutic Targets: Advances and Limitations

(2008) Clemens Scheinecker et al.   IMMUNITY

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

(2008) Marc Feldmann et al.   IMMUNOLOGICAL REVIEWS

Ustekinumab for chronic plaque psoriasis

(2008) Brenda L Bartlett et al.   LANCET

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

(2008) Shumpei Yokota et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET

Gene expression analysis of interferon-β treatment in multiple sclerosis

(2008) F Sellebjerg et al.   Multiple Sclerosis Journal

Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin

(2008) Ausra Milano et al.   PLoS One

Signalling, inflammation and arthritis: Crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity

(2008) V. Paunovic et al.   RHEUMATOLOGY

Interleukin-7 in rheumatoid arthritis

(2008) S. M. Churchman et al.   RHEUMATOLOGY

Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity

(2008) H. P. Carroll et al.   RHEUMATOLOGY

Genetic epidemiology: the use of old and new tools for multiple sclerosis

(2008) Sreeram V. Ramagopalan et al.   TRENDS IN NEUROSCIENCES